Type one diabetics currently must inject themselves with synthetic insulin up to ten times daily. While these existing insulins help to stabilise blood sugar levels when injected into the body ...

Arthur Riggs, whose work with recombinant DNA led to the development of synthetic insulin, has died from complications of lymphoma. He was 82. Born in California on August 8, 1939, Riggs spent his ...

David Goeddel is a pioneer of the biotechnology industry who, employed at the time by Genentech, successfully used genetic engineering to coax bacteria into creating synthetic human insulin, human ...

In a study published in NAR, Fussenegger’s team developed a programmable synthetic circuit to control secretion of a protein of interest after translation. 1 Killing a virus-infected cell, needing ...

These stable, synthetic molecules are highly selective to glucose in complex environments such as blood. The idea behind glucose responsive insulin is to create a therapy that modulates its ...